Opportunity Information: Apply for W81XWH 14 NFRP EHDA
Apply for W81XWH 14 NFRP EHDA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Neurofibromatosis Exploration Hypothesis Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on May 28, 2014 and posted on May 27, 2014.
- Applicants must submit their applications by Jul 24, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,280,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Neurofibromatosis Research Program (NFRP) Exploration Hypothesis Development Award (EHDA) is a grant opportunity run through the Department of the Army (USAMRAA) that is designed to fund early-stage, imaginative neurofibromatosis (NF) research ideas that are too new, too unconventional, or too risky for more traditional funding mechanisms. The central purpose of the award is to support the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts, with the expectation that successful projects will generate the rationale, feasibility, and direction needed for larger follow-on studies and future research programs. This mechanism was first introduced in FY08, and by the time of this FY14 posting, it had received 149 applications with 31 recommended for funding, reflecting both competitive interest and selective support.
A key emphasis of the EHDA is that the proposed project must be built around a well-formulated, testable hypothesis and a strong scientific rationale and study design. Unlike many grant programs that effectively require extensive prior results, this award encourages creativity and new directions, so preliminary and/or published data are welcomed but not required. In other words, applicants can propose a genuinely new concept as long as they can justify why it is scientifically plausible, how it will be tested, and how the work can establish a foundation for subsequent research. The program is explicitly oriented toward hypothesis-driven exploration rather than incremental extensions of existing work.
Innovation is not just encouraged; it is a core review expectation. The announcement makes clear that innovation can take many forms, such as introducing a novel paradigm, challenging an established paradigm, reframing an old problem in a new way, or applying unusually creative approaches to NF research. At the same time, the program draws a hard line against projects that amount to incremental advances built directly on already published data, stating that such proposals do not match the intent of the mechanism. Because of that, the Principal Investigator is expected to clearly and explicitly explain what is innovative about the project and why it represents a meaningful departure from standard approaches in the NF field.
Regarding research involving people, the EHDA allows studies that include human subjects or human anatomical substances, but only under limited regulatory pathways. Any human subjects component must qualify as exempt under 32 CFR 219.101(b) or be eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110. The Institutional Review Board (IRB) of record makes the initial determination of exempt or expedited status, and applicants are responsible for understanding and following their institutional IRB submission requirements. Importantly, studies that do not qualify for exempt or expedited status will be administratively withdrawn, meaning they will be removed from consideration regardless of scientific merit. Clinical trials are specifically not allowed under this funding opportunity; investigators who want to run a clinical trial are directed to the separate FY14 NFRP Clinical Trial Award (W81XWH 14 NFRP CTA). The opportunity also points applicants to a Human Subject Resource Document available in the eBRAP system for additional guidance on clinical research and clinical trial distinctions.
From an administrative and funding standpoint, this opportunity (Funding Opportunity Number W81XWH 14 NFRP EHDA) was posted May 27, 2014, with an application closing date of July 24, 2014, and an archive date of August 23, 2014. It is categorized as a discretionary funding opportunity supporting science and technology and other R&D, and it uses a Grant and Cooperative Agreement funding instrument structure. The estimated total funding listed is $1,280,000, with an anticipated 8 awards, and there is no cost sharing or matching requirement. The CFDA listing is 12.420 (Military Medical Research and Development). Eligibility is described as unrestricted, meaning it is broadly open to applicants of any entity type, subject to any clarifications that might appear in the full announcement. For access issues or applicant support, the posting directs users to the CDMRP eBRAP Help Desk (help@eBRAP.org, 301-682-5507).
FAQs: DoD Neurofibromatosis Research Program (NFRP) Exploration Hypothesis Development Award (EHDA)
What is the Exploration Hypothesis Development Award (EHDA)?
The EHDA is a DoD Neurofibromatosis Research Program (NFRP) funding opportunity administered through the Department of the Army (USAMRAA). It is designed to support early-stage, imaginative neurofibromatosis (NF) research concepts that are too new, too unconventional, or too risky for more traditional funding mechanisms.
What is the main goal of this award mechanism?
The central purpose is to fund initial exploration of innovative, high-risk, high-gain ideas with the expectation that successful projects will generate rationale, feasibility, and direction for larger follow-on studies and future research programs.
What kind of research ideas are a good fit for this opportunity?
This opportunity is intended for hypothesis-driven projects that explore potentially groundbreaking concepts. It is geared toward research directions that are genuinely new and not simply incremental extensions of prior published work.
Does the project need a hypothesis?
Yes. A key emphasis is that the proposed project must be built around a well-formulated, testable hypothesis, supported by a strong scientific rationale and study design.
Are preliminary results or published data required to apply?
No. Preliminary and/or published data are welcomed but not required. Applicants may propose a new concept as long as they can justify scientific plausibility, explain how it will be tested, and show how the work can establish a foundation for subsequent research.
How important is innovation in the EHDA review expectations?
Innovation is a core expectation. The opportunity states that innovation may include introducing a novel paradigm, challenging an established paradigm, reframing an old problem in a new way, or applying unusually creative approaches to NF research.
Are incremental projects considered responsive to the EHDA intent?
No. The announcement draws a clear line against projects that amount to incremental advances built directly on already published data, stating that such proposals do not match the intent of the mechanism.
What should the Principal Investigator (PI) explain about innovation?
The PI is expected to clearly and explicitly explain what is innovative about the project and why it represents a meaningful departure from standard approaches in the NF field.
Are studies involving human subjects allowed?
Yes, but only under limited regulatory pathways. Any human subjects component must qualify as exempt under 32 CFR 219.101(b) or be eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110.
Who determines whether a human subjects study is exempt or eligible for expedited review?
The Institutional Review Board (IRB) of record makes the initial determination of exempt or expedited status, and applicants are responsible for understanding and following their institutional IRB submission requirements.
What happens if the proposed human subjects research does not qualify as exempt or expedited?
It will be administratively withdrawn, meaning it will be removed from consideration regardless of scientific merit.
Are clinical trials allowed under the EHDA?
No. Clinical trials are specifically not allowed under this funding opportunity.
Where should investigators apply if they want to conduct a clinical trial?
The opportunity directs investigators to the separate FY14 NFRP Clinical Trial Award (W81XWH 14 NFRP CTA).
Is there additional guidance available on human subjects research and clinical trial distinctions?
Yes. Applicants are pointed to a Human Subject Resource Document available in the eBRAP system for additional guidance on clinical research and clinical trial distinctions.
What is the Funding Opportunity Number for this award?
The Funding Opportunity Number is W81XWH 14 NFRP EHDA.
When was this funding opportunity posted, and what were the key dates?
It was posted May 27, 2014. The application closing date was July 24, 2014, and the archive date was August 23, 2014.
What type of funding opportunity is this categorized as?
It is categorized as a discretionary funding opportunity supporting science and technology and other R&D.
What funding instrument is used for this opportunity?
The opportunity uses a Grant and Cooperative Agreement funding instrument structure.
How much total funding was estimated, and how many awards were anticipated?
The estimated total funding listed is $1,280,000, with an anticipated 8 awards.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement listed for this opportunity.
What is the CFDA number associated with this program?
The CFDA listing is 12.420 (Military Medical Research and Development).
Who is eligible to apply?
Eligibility is described as unrestricted, meaning it is broadly open to applicants of any entity type, subject to any clarifications that might appear in the full announcement.
How competitive has this award been historically (as of the FY14 posting)?
The mechanism was first introduced in FY08. By the time of this FY14 posting, it had received 149 applications with 31 recommended for funding, reflecting competitive interest and selective support.
Who administers or runs this grant opportunity?
The EHDA is run through the Department of the Army (USAMRAA) under the DoD Neurofibromatosis Research Program (NFRP).
Where can applicants get help with access issues or applicant support?
The posting directs users to the CDMRP eBRAP Help Desk at help@eBRAP.org or 301-682-5507.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Use and Importance of Tributaries to Sustain Native Fish Communities in the San Juan River
Previous opportunity: DoD Neurofibromatosis Clinial Trial Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 14 NFRP EHDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 14 NFRP EHDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| Central Valley Project Conservation Program and Central Valley Project Improvement Act Habitat Restoration Program Apply for R14AS00050 Funding Number: R14AS00050 Agency: Bureau of Reclamation Category: Science and Technology and other Research and Development Funding Amount: $1,000,000 |
| CENTER OF EXCELLENCE Electromagnetic Interference for Extreme Electromagnetic Environments Apply for BAA AFOSR 2014 0002 Funding Number: BAA AFOSR 2014 0002 Agency: Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: $6,000,000 |
| DoD Prostate Cancer Exploration Hypothesis Development Award Apply for W81XWH 14 PCRP EHDA Funding Number: W81XWH 14 PCRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Laboratory Clinical Transition Award Apply for W81XWH 14 PCRP LCTA Funding Number: W81XWH 14 PCRP LCTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Postdoctoral Training Award Apply for W81XWH 14 PCRP PTA Funding Number: W81XWH 14 PCRP PTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Physician Research Training Award Apply for W81XWH 14 PCRP PRTA Funding Number: W81XWH 14 PCRP PRTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Dr. Barbara Terry Koroma Health Disparity Research Award Apply for W81XWH 14 PCRP HDRA Funding Number: W81XWH 14 PCRP HDRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Collaborative Undergraduate Historically Black Colleges and Universities Student Summer Training Program Award Apply for W81XWH 14 PCRP STPA Funding Number: W81XWH 14 PCRP STPA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Population Science Impact Award Apply for W81XWH 14 PCRP PSIA Funding Number: W81XWH 14 PCRP PSIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Early Stage Innovations (ESI) Apply for NNH14ZOA001N 14ESI B2 Funding Number: NNH14ZOA001N 14ESI B2 Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| Tribal Colleges and Universities Program Apply for 14 572 Funding Number: 14 572 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
| ADVANCE Increasing the Participation and Advancement of Women in Academic Science and Engineering Careers Apply for 14 573 Funding Number: 14 573 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $4,000,000 |
| Cooperative Ecosystem Studies Unit, Great Basin Apply for G14AS00076 Funding Number: G14AS00076 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Investigator Initiated Research Award Apply for W81XWH 14 SCIRP IIRA Funding Number: W81XWH 14 SCIRP IIRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Qualitative Research Award Apply for W81XWH 14 SCIRP QRA Funding Number: W81XWH 14 SCIRP QRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Translational Research Award Apply for W81XWH 14 SCIRP TRA Funding Number: W81XWH 14 SCIRP TRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Clinical Trial Award Apply for W81XWH 14 SCIRP CTA Funding Number: W81XWH 14 SCIRP CTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Methodology, Measurement, and Statistics Apply for 14 574 Funding Number: 14 574 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Southern Appalachian Mountains CESU Apply for G14AS00087 Funding Number: G14AS00087 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, North Atlantic Coast Apply for G14AS00079 Funding Number: G14AS00079 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 14 NFRP EHDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
